Validating targets for antiparasite chemotherapy

Parasitology

Volumn 114, Issue SUPPL. 1, 1997, Pages

  Wang, C C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dihydrofolate reductase thymidylate synthetase; Dihydropteroate synthetase; Glycosome; Lanosterol C 14 demethylase; Nucleoside phosphotransferase; Purine phosphoribosyltransferase; Pyruvate: ferredoxin oxidoreductase; Trypanothione reductase

Indexed keywords

2 (2,4 DIFLUOROPHENYL) 1 [3 [2 [4 (2,2,3,3 TETRAFLUOROPROPOXY)PHENYL]VINYL] 1,2,4 TRIAZOL 1 YL] 3 (1,2,4 TRIAZOL 1 YL) 2 PROPANOL; ALLOPURINOL; ALLOPURINOL RIBOSIDE; ATOVAQUONE; EFLORNITHINE; METRONIDAZOLE; NIFURTIMOX; PYRIMETHAMINE; SULFADOXINE;

AFRICAN TRYPANOSOMIASIS; APICOMPLEXA; CHEMOTHERAPY; CONFERENCE PAPER; DRUG TRANSPORT; ENZYME INHIBITION; NEMATODE; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; PROTOZOAL INFECTION; TRYPANOSOMA CRUZI;

ANIMALS; ANTIPARASITIC AGENTS; ARTHROPODS; ENZYME INHIBITORS; NEMATODA; PARASITES; PARASITIC DISEASES; PROTOZOA;

APICOMPLEXA; PROTOZOA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0030883947     PISSN: 00311820     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0031182097001017     Document Type: Article

References (105)

1. ALDRITT, S. M., TIEN, P. & WANG, C. C. (1985). Pyrimidine salvage in Giardia lamblia. Journal of Experimental Medicine 161, 437-445.
2. AOYAMA, Y., FUNAE, Y., NOSHIRO, M., HORIUCHI, T. & YOSHIDA, Y. (1994). Occurrence of a P450 showing high homology to yeast lanosterol 14 α-demethylase (P45014DM) in the rat liver. Biochemistry and Biophysics Research Communications 201, 1320-1326.
3. ARAUJO, F. G., HUSKINSON-MARK, J., GUTTERIDGE, W. E. & REMINGTON, J. S. (1992). In vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against the cyst form of Toxoplasma gondii. Antimicrobial Agents and Chemotherapy 36, 326-330.
4. BASS, K. E., SOMMER, J. M., CHENG, Q.-L. & WANG, C. C. (1992). Mouse ornithine decarboxylase is stable in Trypanosoma brucei. Journal of Biological Chemistry 267, 11034-11037.
5. BEACH, D. H., GOAD, L. J. & HOLZ, G. G., JR. (1988). Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes. Molecular and Biochemical Parasitology 31, 149-162.
6. BERENS, R. L., KRUG, E. C. & MARR, J. J. (1995). Purine and pyrimidine metabolism. In: Biochemistry and Molecular Biology of Parasites (eds. Marr, J. J. and Muller, M.), pp. 89-117. London: Academic Press.
7. BLATTNER, J., SWINKELS, B., DORSAM, H., PROSPERO, T., SUBRAMANI, S. & CLAYTON, C. E. (1992). Glycosome assembly in trypanosomes: variations in the acceptable degeneracy of a COOH-terminal microbody targeting signal. Journal of Cell Biology 119, 1129-1136.
8. BROHN, F. H. & CLARKSON, A. B., JR. (1980). Trypanosoma brucei brucei: Patterns of glycolysis at 37°C in vitro. Molecular and Biochemical Parasitology 1, 291-305.
9. BROOKS, D. R., WANG, P., READ, M., WATKINS, W. M., SIMS, P. F. & HYDE, J. E. (1994). Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydro-pteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. European Journal of Biochemistry 224, 397-405.
10. CAMPBELL, W. C., FISHER, M. H., STAPLEY, E. O., ALBERS-SCHONBERG, G. & JACOB, T. A. (1983). Invermectin: A potent new antiparasitic agent. Science 221, 823-828.
11. CARSON, D. A. & CHANG, K.-P. (1981). Phosphorylation and anti-leishmanial activity of formycin B. Biochemistry and Biophysics Research Communications 100, 1377-1383.
12. CHAUDHURI, M., AJAYI, W., TEMPLE, S. & HILL, G. C. (1995). Identification and partial purification of a stage-specific 33 kDa mitochondrial protein as the alternative oxidase of the Trypanosoma brucei bruei bloodstream trypomastigotes. Journal of Eukaryotic Microbiology 42, 467-472.
13. CHAUDHURI, M. & HILL, G. C. (1996). Cloning, sequencing and functional activity of the Trypanosoma brucei brucei alternative oxidase. Molecular and Biochemical Parasitology 83, 125-129.
14. CHIN, M. S. & WANG, C. C. (1994). Isolation, sequencing and expression of the gene encoding hypoxanthine-guanine-xanthine phosphoribosyltransferase of Tritrichomonas foetus. Molecular and Biochemical Parasitology 63, 221-230.
15. CLAYTON, C. E. & MICHELS, P. (1996). Metabolic compartmentation in African trypanosomes. Parasitology Today 12, 465-471.
16. CULLY, D. F., VASSALATIS, D. K., LIU, K. K., PARESS, P. S., VAN DER PLOEG, L. H. T., SCHAEFFER, J. M. & ARENA, J. P. (1994). Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans. Nature 371, 707-710.
17. DIECKMANN, A. & JUNG, A. (1986). Mechanisms of sulfadoxine resistance in Plasmodium falciparum. Molecular and Biochemical Parasitology 19, 143-147.
18. DONALD, R. G. K., CARTER, D., ULLMAN, B. & ROOS, D. S. (1996). Insertional tagging, cloning and expression of the Toxoplasma gondii hypoxanthine-xanthine-guanine phosphoribosyltransferase gene: Use as a selectable marker for stable transformation. Journal of Biological Chemistry 271, 14010-14019.
19. DOVEY, H. F., McKERROW, J. H. & WANG, C. C. (1984). Purine salvage in Schistosoma mansoni schistosomules. Molecular and Biochemical Parasitology 11, 157-167.
20. EADS, J. C., SCAPIN, G., XU, Y., GRUBMEYER, C. & SACCHETINI, J. C. (1994). The crystal structure of human hypoxanthine-guanine phosphoribosyltransferase with bound GMP. Cell 78, 325-334.
21. ELLIS, J. E. (1994). Coenzyme Q homologs in parasitic protozoa as targets for chemotherapeutic attack. Parasitology Today 10, 296-301.
22. FAIRLAMB, A. H. & CERAMI, A. (1992). Metabolism and functions of trypanothione in the kinetoplastida. Annual Review of Microbiology 46, 695-729.
23. FAIRLAMB, A. H., CARTER, N. S., CUNNINGHAM, M. & SMITH, K. (1992). Characterisation of melarsen-resistant Trypanosoma brucei brucei with respect to cross-resistance to other drugs and trypanothione metabolism. Molecular and Biochemical Parasitology 53, 213-222.
24. FAIRLAMB, A. H., HENDERSON, G. B., BACCHI, C. J. & CERAMI, A. (1987). In vivo effects of difluoromethylornithine on trypanothione and polyamine levels in bloodstream forms of Trypanosoma brucei. Molecular and Biochemical Parasitology 24, 185-191.
25. FAIRLAMB, A. H., HENDERSON, G. B. & CERAMI, A. (1989). Trypanothione is the primary target for arsenical drugs against African trypanosomes. Proceedings of the National Academy of Sciences, USA 86, 2607-2611.
26. FERONE, R. (1973). The enzymic synthesis of dihydropteroate and dihydrofolate by Plasmodium berghei. Journal of Protozoology 20, 459-464.
27. FERONE, R. (1977). Folate metabolism in malaria. Bulletin of the World Health Organization 55, 291-298.
28. 1a irreversibly blocks post-synaptic potentials at the lobster neuromuscular junction by reducing muscle membrane resistance. Proceedings of the National Academy of Sciences, USA 76, 2061-2066.
29. FRY, M. & PUDNEY, M. (1992). Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566C80). Biochemical Pharmacology 43, 1545-1553.
30. GAHL, W. A. & PITOT, H. C. (1979). Putrescine oxidase activity in adult bovine serum and fetal bovine serum. In Vitro 15, 252-257.
31. GIFFIN, B. F., McCANN, P. P., BITONTI, A. J. & BACCHI, C. J. (1986). Polyamine depletion following exposure to DL-α-difluoromethylornithine both in vivo and in vitro initiates morphological alterations and mitochondrial activation in a monomorphic strain of Trypanosoma brucei brucei. Journal of Protozoology 3, 238-243.
32. GOAD, L. J., BERENS, R. L., MARR, J. J., BEACH, D. H. & HOLZ, G. G., JR. (1989). The activity of ketoconazole and other azoles against Trypanosoma cruzi: biochemistry and chemotherapeutic action in vitro. Molecular and Biochemical Parasitology 32, 179-190.
33. GOULD, S. J., KELLER, G.-A., HOSKEN, N., WILKINSON, J. & SUBRAMANI, S. (1989). A conserved tripeptide sorts proteins to peroxisomes. Journal of Cell Biology 108, 1657-1667.
34. HAMANN, L., NICKEL, R. & TANNICH, E. (1995). Transfection and continuous expression of heterologous genes in the protozoan parasite Entamoeba histolytica. Proceedings of the National Academy of Sciences, USA 92, 8975-8979.
35. HAUGHAN, P. A. & GOAD, L. J. (1991). Lipid biochemistry of trypanosomatids. In: Biochemical Protozoology, (ed. Coombs, G. and North, M.), pp. 312-328. London: Taylor and Francis.
36. HEYWORTH, P. G., GUTTERIDGE, W. E. & GINGER, C. D. (1982). Purine metabolism in Trichomonas vaginalis. FEBS Letters 141, 106-110.
37. HRDY, I. & MULLER, M. (1995). Primary structure and eubarcterial relationships of the pyruvate: ferredoxin oxidoreductase of the amitochondriate eukaryote Trichomonas vaginalis. Journal of Molecular Evolution 41, 388-396.
38. IVANETICH, K. M. & SANTI, D. V. (1990). Bifunctional thymidylate synthetase-dihydrofolate reductase in protozoa. FASEB Journal 4, 1591-1597.
39. JOHNSON, P. J. (1993). Metronidazole and drug resistance. Parasitology Today 9, 183-186.
40. KAGER, P. A., REES, P. H., WELLDE, P. T., HOCKMEYER, W. T. & LYERLY, W. H. (1981). Allopurinol in the treatment of visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 75, 556-559.
41. KALB, V. F., LOPER, J. C., DEY, C. R., WOODS, C. W. & SUTTER, T. R. (1986). Isolation of a cytochrome P-450 structural gene from Saccharomyces cerevisiae. Gene 45, 237-245.
42. KALB, V. F., WOODS, C. W., TURI, T. G., DEY, C. R., SUTTER, T. R. & LOPER, J. C. (1987). Primary structure of the P450 lanosterol demethylase gene from Saccharomyces cerevisiae. DNA 6, 529-537.
43. 1a, a new paralyzing anthelmintic that affects interneurons and inhibitory motoneurons in Ascaris. Proceedings of the National Academy of Sciences, USA 77, 6211-6215.
44. KELLY, J. M., TAYLOR, M. C., SMITH, K., HUNTER, K. J. & FAIRLAMB, A. H. (1993). Phenotype of recombinant Leishmania donovani and Trypanosoma cruzi which over express trypanothione reductase: sensitivity towards agents that are thought to induce oxidative stress. European Journal of Biochemistry 218, 29-37.
45. KING, D. J., WISEMAN, A., KELLY, D. E. & KELLY, S. L. (1985). Differences in the cytochrome P-450 enzymes of sterol C-14 demethylase mutants of Saccharomyces cerevisiae. Current Genetics 10, 261-267.
46. KRAUTH-SEIGEL, R. L. & SCHÖNECK, R. (1995). Trypanothione reductase and lipoamide dehydrogenase as targets for a structure-based drug design. FASEB Journal 9, 1138-1146.
47. KRUNGKRAI, J., WEBSTER, H. K. & YUTHAVONG, Y. (1989). De novo and salvage biosynthesis of pteroylpentaglutamates in the human malaria parasite, Plasmodium falciparum. Molecular and Biochemical Parasitology 32, 25-38.
48. KURIYAN, J., KONG, X.-P., KRISHNA, T. S. R., SWEET, R. M., MURGOLO, N. J., FIELD, H., CERAMI, A. & HENDERSON, G. B. (1991). X-ray structure of trypanothione reductase from Crithidia fasciculata at 2.4 Å resolution. Proceedings of the National Academy of Sciences, USA 88, 8764-8768.
49. LI, F.-S., HUA, S.-B., WANG, C. C. & GOTTESDIENER, K. M. (1996). Procyclic Trypanosoma brucei cell lines deficient in ornithine decarboxylase activity. Molecular and Biochemical Parasitology 78, 227-236.
50. LO, H.-S. & WANG, C. C. (1985). Purine salvage in Entamoeba histolytica. Journal of Parasitology 71, 662-670.
51. LOOKER, D. L., MARR, J. J. & BERENS, R. L. (1986). Mechanisms of action of pyrazolopyrimidines in Leishmania donovani. Journal of Biological Chemistry 261, 9412-9415.
52. MARR, J. J. & BERENS, R. L. (1983). Mini Review: Pyrazolopyrimidine, metabolism in the pathogenic trypanosomatidae. Molecular and Biochemical Parasitology 7, 339-356.
53. MCHARDY, N. (1992). Butalex (buparvaquone): A new therapeutic for theileriosis. In: Recent Developments in the Research and Control of Theileria annulata (ed. Dolan, T. T.), pp. 59-66. Nairobi: ILRAD.
54. MILFORD, F., PEPIN, J., LOKO, L., ETHIER, L. & MPIA, B. (1992). Efficacy and toxicity of eflornithine for the treatment of Trypanosoma brucei gambiense sleeping sickness. Lancet 340, 652-655.
55. MINAGAWA, N., YABU, Y., KITA, K., NAGAI, K., OHTA, N., MEGURO, K., SAKAJO, S. & YOSHIMOTO, A. (1996). An antibiotic, ascofuranone, specifically inhibits respiration and in vitro growth of long slender bloodstream forms of Trypanosoma brucei brucei. Molecular and Biochemical Parasitology 81, 127-136.
56. MÜLLER, M. (1980). The Hydrogenosome. Symposia of the Society of General Microbiology 30, 127-142.
57. MÜLLER, M. (1986). Reductive activation of nitroimidazoles in anaerobic microorganisms. Biochemical Pharmacology 35, 37-41.
58. NELSON, D. J., LAPON, S. W., TUTTLE, J. V., MILLER, W. H., MILLER, R. L., KRENITSKY, T. A., ELION, G. B., BERENS, R. S. & MARR, J. J. (1979). Allopurinol ribonucleoside as an antileishmanial agent: biological effects, metabolism and enzymatic phosphorylation. Journal of Biological Chemistry 254, 11544-11549.
59. OPPERDOES, F. R. & BORST, P. (1977). Localisation of nine glycolytic enzymes in a microbody-like organelle in Trypanosoma brucei: the glycosome. FEBS Letters 80, 360-364.
60. OPPERDOES, F. R. & MICHELS, P. A. M. (1993). The glycosomes of the Kinetoplastida. Biochimie 75, 231-234.
61. PETERSON, D. S., MILHOUS, W. K. & WELLEMS, T. E. (1990). Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proceedings of the National Academy of Sciences, USA 87, 3018-3022.
62. PHILLIPS, M. A., COFFINO, P. & WANG, C. C. (1987). Cloning and sequencing of the ornithine decarboxylase gene from Trypanosoma brucei: implications for enzyme turnover and selective difluoromethylornithine inhibition. Journal of Biological Chemistry 262, 8721-8727.
63. 1a modulation of γ-aminobutyric acid receptors in rat brain membranes. Journal of Neurochemistry 38, 375-379.
64. POULIN, R., LU, L., ACKERMANN, B., BEY, P. & PEGG, A. E. (1992). Mechanism of the irreversible inactivation of mouse ornithine decarboxylase by α-difluoromethylornithine: characterisation of sequences at the inhibitor and coenzyme binding sites. Journal of Biological Chemistry 267, 150-158.
65. REEVES, R. E., WARREN, G., SUSKIND, B. & LO, H. S. (1977). An energy-conserving pyruvate-to-acetate pathway in Entamoeba histolytica. Journal of Biological Chemistry 252, 726-731.
66. RODRIGUEZ, M. A., HIDALOO, M. E., SANCHEZ, T. & OROZCO, E. (1996). Cloning and characterisation of the Entamoeba histolytica pyruvate : ferredoxin oxidoreductase gene. Molecular and Biochemical Parasitology 78, 273-277.
67. ROGERS, S., WELLS, R. & RECHSTEINER, M. (1986). Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234, 364-368.
68. SAENZ, R. E., PAZ, H. M., JOHNSON, C. M., MARR, J. J., NELSON, D. J., PATTISHALL, K. H. & ROGERS, M. D. (1989). Treatment of American cutaneous leishmaniasis with orally administered allopurinol riboside. Journal of Infectious Diseases 160, 153-158.
69. SCHECHTER, P. J. & SJOERDSMA, A. (1986). Difluoromethylornithine in the treatment of African trypanosomiasis. Parasitology Today 23, 223-224.
70. SCHOFIELD, P. J., EDWARDS, M. R. & KRANTZ, P. (1991). Glucose metabolism in Giardia lamblia. Molecular and Biochemical Parasitology 45, 39-47.
71. SCHWARTZMAN, J. C. & PFEFFERKORN, E. R. (1982). Toxoplasma gondii: purine synthesis and salvage in mutant host cells and parasites. Experimental Parasitology 53, 77-86.
72. SEEGMILLER, J. E., ROSENBLOOM, F. M. & KELLEY, W. N. (1967). Enzyme defect associated with a sex-linked human neurological excessive purine synthesis. Science 144, 1682-1684.
73. SIRAWARAPORN, W., PRAPUNWATTANA, P. L., SIRAWARAPORN, R., YUTHAVONG, Y. & SANTI, D. V. (1993). The dihydrofolate reductase domain of Plasmodium falciparum thymidylate synthase-dihydrofolate reductase: gene synthesis, expression and anti-folate resistant mutants. Journal of Biological Chemistry 268, 21637-21644.
74. SOMMER, J. M., CHENG, Q. L., KELLER, G.-A. & WANG, C. C. (1992). In vitro import of firefly luciferase into the glycosomes of Trypanosoma brucei and mutational analysis of the C-terminal targeting signal. Molecular Biology of the Cell 3, 749-759.
75. SOMMER, J. M., HUA, S.-B., LI, F.-S., GOTTESDIENER, K. M. & WANG, C. C. (1996). Cloning by functional complementation in Trypanosoma brucei. Molecular and Biochemical Parasitology 76, 83-89.
76. SOMMER, J. M. & WANG, C. C. (1994). Targeting proteins to the glycosomes of African trypanosomes. Annual Reviews in Microbiology 48, 105-138.
77. SOMOZA, J. R., CHIN, M. S., FOCIA, P. J., WANG, C. C. & FLETTERICK, R. J. (1996). The crystal structure of the hypoxanthine-guanine-xanthine phosphoribosyltransferase from the protozoan parasite Tritrichomonas foetus. Biochemistry 35, 7032-7040.
78. STRÖMSTEDT, M., ROZMAN, D. & WATERMAN, M. R. (1996). The ubiquitously expressed human CYP51 encodes lanosterol 14 α-demethylase, a cytochrome P-450 whose expression is regulated by oxysterols. Archives of Biochemistry and Biophysics 329, 73-81.
79. TABOR, C. W. & TABOR, H. (1984). Polyamines. Annual Review of Biochemistry 53, 749-790.
80. TOWNSON, S. M., UPCROFT, J. A. & UPCROFT, P. (1996). Characterisation and purification of pyruvate: ferredoxin oxidoreductase from Giardia duodenalis. Molecular and Biochemical Parasitology 79, 183-194.
81. TRIGLIA, T. & COWMAN, A. F. (1994). Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proceedings of the National Academy of Sciences, USA 91, 7149-7153.
82. TRZASKOS, J. M. & HENRY, M. J. (1989). Comparative effects of the azole-based fungicide flusilazole on yeast and mammalian lanosterol 14 α-methyl demethylase. Antimicrobial Agents and Chemotherapy 33, 1228-1231.
83. TRZASKOS, J., KAWATA, S. & GAYLOR, J. L. (1986). Microsomal enzymes of cholesterol biosynthesis. Purification of lanosterol 14α-methyl demethylase cytochrome P-450 from hepatic microsomes. Journal of Biological Chemistry 261, 14651-14657.
84. TUTTLE, J. V. & KRENITSKY, T. A. (1980). Purine phosphoribosyltransferases from Leishmania donovani. Journal of Biological Chemistry 255, 909-916.
85. URBINA, J. A., PAYARES, G., MOLINA, J., SANOJA, C., LIENDO, A., LAZARDI, K., PIRAS, M. M., PIRAS, R., PEREZ, N., WINCKER, P. & RYLEY, J. F. (1996). Cure of short-and long-term experimental Chagas' disease using D0870. Science 273, 969-971.
86. VAIDYA, A. B., LASHGARI, M. S., POLOGE, L. G. & MORRISEY, J. (1993). Structural features of Plasmodium cytochrome b that underlie susceptibility to 8-aminoquinolines and hydroxynaphthoquinones. Molecular and Biochemical Parasitology 58, 33-42.
87. VAN DER MEER, C., VERSHIJS-BROERS, J. A. M. & OPPERDOES, F. R. (1979). Trypanosoma brucei: trypanocidal effect of salicylhydroxamic acid plus glycerol in infected rats. Experimental Parasitology 48, 126-134.
88. VERLINDE, C. L., CALLENS, M., VAN CALENBERGH, S., VAN AERSCHOT, A., HERDEWIJN, P., HANNAERT, V., MICHELS, P. A., OPPERDOES, F. R. & HOL, W. G. (1994). Selective inhibition of trypanosomal glyceraldehyde-3-phosphate dehydrogenase by protein structure-based design: towards new drugs for the treatment of sleeping sickness. Journal of Medicinal Chemistry 37, 3605-3613.
89. VINES, R. R., PURDY, J. E., RAGLAND, B. D., SAMUELSON, J., MANN, B. J. & PETRI, W. A., JR. (1995). Stable episomal transfection of Entamoeba histolytica. Molecular and Biochemical Parasitology 71, 264-267.
90. VISSER, N. & OPPERDOES, F. R. (1980). Glycolysis in Trypanosoma brucei. European Journal of Biochemistry 103, 623-632.
91. VISSER, N., OPPERDOES, F. R. & BORST, P. (1981). Subcellular compartmentation of glycolytic intermediates in Trypanosoma brucei. European Journal of Biochemistry 118, 521-526.
92. WANG, C. C. (1975). Studies of the mitochondria from Eimeria tenella and inhibition of mitochondrial electron transport by quinolone coccidiostats. Biochimica et Biophysica Acta 396, 210-219.
93. WANG, C. C. (1976). Inhibition of the respiration of Eimeria tenella by quinolone coccidiostats. Biochemical Pharmacology 25, 343-349.
94. WANG, C. C. (1982). Current problems in anti-parasite chemotherapy. Trends in Biochemical Science 7, 354-356.
95. WANG, C. C. (1984). Parasitic enzymes as potential targets for antiparasitic chemotherapy. Journal of Medicinal Chemistry 27, 1-9.
96. WANG, C. C. (1995). Molecular mechanisms and therapeutic approaches to the treatment of African trypanosomes. Annual Review of Pharmacology and Toxicology 35, 93-127.
97. WANG, C. C. & ALDRITT, S. M. (1983). Purine salvage networks in Giardia lamblia. Journal of Experimental Medicine 158, 1703-1712.
98. WANG, C. C., VERHAM, R., RICE, A. & TZENG, S.-F. (1983a). Purine salvage by Tritrichomonas foetus. Molecular and Biochemical Parasitology 8, 325-337.
99. WANG, C. C., VERHAM, R., TZENG, S.-F., ALDRITT, S. M. & CHENG, H.-W. (1983b). Pyrimidine metabolism in Tritrichonomas foetus. Proceedings of the National Academy of Sciences, USA 80, 2564-2568.
100. WERNSDORFER, W. H. & PAYNE, D. (1991). The dynamics of drug resistance in Plasmodium falciparum. Pharmacology and Therapeutics 50, 95-121.
101. YEE, J. & NASH, T. E. (1995). Transient transfection and expression of firefly luciferase in Giardia lamblia. Proceedings of the National Academy of Sciences, USA 92, 5615-5619.
102. 14DM purified from Saccharomyces cerevisiae microsomes. Biochemical Pharmacology 36, 229-235.
103. YU, D. C., WANG, A. L., WU, C.-H. & WANG, C. C. (1995). Virus-mediated expression of firefly luciferase in the parasitic protozoan Giardia lamblia. Molecular Cell Biology 15, 4867-4872.
104. YUAN, L., CRAIG, S. P. III, McKERROW, J. H. & WANG, C. C. (1990). The hypoxanthine-guanine phosphoribosyltransferase of Schistosoma mansoni: further characterisation and gene expression in Escherichia coli. Journal of Biological Chemistry 265, 13528-13532.
105. ZHANG, Y. & MESHNICK, S. R. (1991). Inhibition of Plasmodium falciparum dihydropteroate synthetase and growth in vitro by sulfa drugs. Antimicrobial Agents and Chemotherapy 35, 267-271.